We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Most Drugmakers Keep Postmarket Agreements
FDA: Most Drugmakers Keep Postmarket Agreements
November 12, 2010
The FDA reports that most sponsors’ required postmarket clinical trials are on schedule.